FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976640978> ?p ?o ?g. }

• W1976640978 endingPage "55" @default.
• W1976640978 startingPage "49" @default.
• W1976640978 abstract "AimsTwo recent meta-analyses have shown a survival advantage for the addition of concurrent chemotherapy to radiotherapy in the treatment of cervical cancer. However, there is insufficient information available on late toxicity and few data from UK practice. The aims of this study were to examine treatment outcomes (survival and toxicity) in patients with cervical cancer treated with chemoradiation and to compare these with outcomes in patients treated with radiation alone.Materials and methodsBetween July 2000 and December 2003, 75 patients with cervical cancer were treated with chemoradiation. Case notes were reviewed retrospectively. Acute and late toxicity were recorded, with late toxicity graded using the Franco-Italian glossary. The median age was 47 years. All patients were staged with examination under anaesthesia and magnetic resonance imaging scans. Forty-two patients were treated with concurrent chemoradiation alone and 33 patients were treated with a combination of neoadjuvant and concurrent chemoradiation. This was due to waiting list problems. The chemotherapy used was cisplatin 40 mg/m2 weekly with radiotherapy, (the neoadjuvant dose was 60 mg/m2 3 weekly). External beam radiotherapy was given to the pelvis (40–45 Gy/20 fractions/4 weeks) followed by low dose rate brachytherapy (22.5–32.5 Gy to point A). Patients who were unable to have brachytherapy were given an external beam boost (15–20 Gy/8–10 fractions).ResultsThe 3-year overall survival rate was 70%, with an estimated 5-year overall survival rate of 60%. The 3-year disease-free survival was 63.6%, with an estimated 5-year disease-free survival rate of 55%. Compared with the cohort of 183 patients from the Christie Hospital in a 1993 audit, there was a trend towards improved overall survival from 49 to 60% (P=0.06), which may become significant with longer follow-up. There were seven patients (9.3%) with grade 3 toxicity and no cases of grade 4 toxicity. In comparison with patients treated in the 1993 audit, the late toxicity rate has increased from 3.4 to 9.3%, but this was not statistically significant (P=0.14).ConclusionThere was a trend towards improved survival with concurrent chemoradiation in this cohort of patients that may become significant with longer follow-up." @default.
• W1976640978 created "2016-06-24" @default.
• W1976640978 creator A5013910748 @default.
• W1976640978 creator A5016066980 @default.
• W1976640978 creator A5029123237 @default.
• W1976640978 creator A5041912741 @default.
• W1976640978 creator A5054787753 @default.
• W1976640978 date "2009-02-01" @default.
• W1976640978 modified "2023-09-23" @default.
• W1976640978 title "Clinical Outcome for Chemoradiotherapy in Carcinoma of the Cervix" @default.
• W1976640978 cites W1935824237 @default.
• W1976640978 cites W1971653050 @default.
• W1976640978 cites W1975536614 @default.
• W1976640978 cites W1986985303 @default.
• W1976640978 cites W1987119935 @default.
• W1976640978 cites W1990828990 @default.
• W1976640978 cites W2005438171 @default.
• W1976640978 cites W2011790890 @default.
• W1976640978 cites W2013130053 @default.
• W1976640978 cites W2018568783 @default.
• W1976640978 cites W2022636355 @default.
• W1976640978 cites W2039784103 @default.
• W1976640978 cites W2056111356 @default.
• W1976640978 cites W2066246663 @default.
• W1976640978 cites W2075543032 @default.
• W1976640978 cites W2090546102 @default.
• W1976640978 cites W2110057444 @default.
• W1976640978 cites W2128327804 @default.
• W1976640978 cites W2132347397 @default.
• W1976640978 cites W2137347661 @default.
• W1976640978 cites W2152292894 @default.
• W1976640978 cites W2157719711 @default.
• W1976640978 cites W2158005966 @default.
• W1976640978 cites W2167925206 @default.
• W1976640978 cites W2314753133 @default.
• W1976640978 cites W2324392028 @default.
• W1976640978 cites W2328935341 @default.
• W1976640978 doi "https://doi.org/10.1016/j.clon.2008.10.014" @default.
• W1976640978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19081712" @default.
• W1976640978 hasPublicationYear "2009" @default.
• W1976640978 type Work @default.
• W1976640978 sameAs 1976640978 @default.
• W1976640978 citedByCount "31" @default.
• W1976640978 countsByYear W19766409782012 @default.
• W1976640978 countsByYear W19766409782013 @default.
• W1976640978 countsByYear W19766409782014 @default.
• W1976640978 countsByYear W19766409782015 @default.
• W1976640978 countsByYear W19766409782016 @default.
• W1976640978 countsByYear W19766409782018 @default.
• W1976640978 countsByYear W19766409782019 @default.
• W1976640978 countsByYear W19766409782020 @default.
• W1976640978 countsByYear W19766409782021 @default.
• W1976640978 countsByYear W19766409782022 @default.
• W1976640978 crossrefType "journal-article" @default.
• W1976640978 hasAuthorship W1976640978A5013910748 @default.
• W1976640978 hasAuthorship W1976640978A5016066980 @default.
• W1976640978 hasAuthorship W1976640978A5029123237 @default.
• W1976640978 hasAuthorship W1976640978A5041912741 @default.
• W1976640978 hasAuthorship W1976640978A5054787753 @default.
• W1976640978 hasBestOaLocation W19766409781 @default.
• W1976640978 hasConcept C121608353 @default.
• W1976640978 hasConcept C126322002 @default.
• W1976640978 hasConcept C126838900 @default.
• W1976640978 hasConcept C141071460 @default.
• W1976640978 hasConcept C143998085 @default.
• W1976640978 hasConcept C2775908122 @default.
• W1976640978 hasConcept C2776283816 @default.
• W1976640978 hasConcept C2776694085 @default.
• W1976640978 hasConcept C2777416452 @default.
• W1976640978 hasConcept C2777740455 @default.
• W1976640978 hasConcept C2778220009 @default.
• W1976640978 hasConcept C2778424827 @default.
• W1976640978 hasConcept C509974204 @default.
• W1976640978 hasConcept C71924100 @default.
• W1976640978 hasConceptScore W1976640978C121608353 @default.
• W1976640978 hasConceptScore W1976640978C126322002 @default.
• W1976640978 hasConceptScore W1976640978C126838900 @default.
• W1976640978 hasConceptScore W1976640978C141071460 @default.
• W1976640978 hasConceptScore W1976640978C143998085 @default.
• W1976640978 hasConceptScore W1976640978C2775908122 @default.
• W1976640978 hasConceptScore W1976640978C2776283816 @default.
• W1976640978 hasConceptScore W1976640978C2776694085 @default.
• W1976640978 hasConceptScore W1976640978C2777416452 @default.
• W1976640978 hasConceptScore W1976640978C2777740455 @default.
• W1976640978 hasConceptScore W1976640978C2778220009 @default.
• W1976640978 hasConceptScore W1976640978C2778424827 @default.
• W1976640978 hasConceptScore W1976640978C509974204 @default.
• W1976640978 hasConceptScore W1976640978C71924100 @default.
• W1976640978 hasIssue "1" @default.
• W1976640978 hasLocation W19766409781 @default.
• W1976640978 hasLocation W19766409782 @default.
• W1976640978 hasOpenAccess W1976640978 @default.
• W1976640978 hasPrimaryLocation W19766409781 @default.
• W1976640978 hasRelatedWork W2140598279 @default.
• W1976640978 hasRelatedWork W2174266008 @default.
• W1976640978 hasRelatedWork W2404042595 @default.
• W1976640978 hasRelatedWork W2513916013 @default.
• W1976640978 hasRelatedWork W2966036943 @default.

• next